ZC3HC1 rs11556924: What Your Genotype Means

What each genotype means

Genomic Location and Molecular Variant

The single nucleotide polymorphism rs11556924 is situated on chromosome 7 at cytogenetic band 7q32.2 within the ZC3HC1 gene, according to records in [dbSNP](https://www.ncbi.nlm.nih.gov/snp/rs11556924). The variant represents a C-to-T transition in exon 8 of the coding transcript. This alteration causes a nonsynonymous missense mutation that substitutes an arginine residue with histidine at position 363 (p.Arg363His). Most genome-wide association study (GWAS) signals linked to cardiovascular traits map to non-coding intronic or intergenic regulatory elements. In contrast, rs11556924 is notable because it directly alters the protein-coding sequence of the resulting polypeptide. Extensive linkage disequilibrium analyses indicate that rs11556924 serves as its own lead functional variant rather than simply tagging an adjacent causal mutation. Because it alters an amino acid in a functional protein domain, researchers have prioritized rs11556924 to investigate the direct cellular and molecular mechanisms linking genetic architecture to vascular wall biology.

Biological Function of the ZC3HC1 Gene and NIPA

The ZC3HC1 gene encodes a scaffold protein originally identified as NIPA (Nuclear Interacting Partner of Anaplastic Lymphoma Kinase), documented in [NCBI Gene](https://www.ncbi.nlm.nih.gov/gene/51530). NIPA plays an essential role as an oscillating component of an SCF-type E3 ubiquitin ligase complex that controls the progression of cells through mitosis. Specifically, NIPA regulates the nuclear accumulation and degradation of cyclin B1, ensuring that cell division proceeds with precise timing. Functional laboratory investigations demonstrate that the p.Arg363His amino acid substitution changes the phosphorylation dynamics of NIPA and alters its nuclear mobility and turnover. In cell models, these molecular changes perturb normal cell cycle progression, leading to reduced rates of vascular and endothelial cell growth. Because coronary artery remodeling and plaque formation depend on the orderly proliferation, survival, and death of vascular smooth muscle cells and endothelial layers, subtle shifts in cell cycle control over decades are thought to influence vascular integrity.

Cardiovascular Research and Evidence Strength

Large meta-analyses from the CARDIoGRAM consortium and entries in the [GWAS Catalog](https://www.ebi.ac.uk/gwas/search?query=rs11556924) have linked rs11556924 to coronary artery disease (CAD). In these population cohorts, the major C allele is statistically associated with a modestly increased risk of CAD, while the minor T allele is linked to a relative protective effect against developing coronary events. Further observational cohorts have reported correlations between the CC genotype, elevated diastolic blood pressure, and increased carotid intima-media thickness in specific patient groups. Nevertheless, the clinical evidence strength is categorized as limited. Cardiovascular disease is a complex, multifactorial outcome shaped by hundreds of genetic variants alongside major lifestyle and environmental determinants. Having a particular allele confers only a very slight percentage difference in lifetime risk, and the variant has not been demonstrated to cause monogenic cardiovascular disorders.

Population Distribution and Ancestral Patterns

Allele frequencies for rs11556924 vary widely across ancestral groups. Large population genomics databases such as [gnomAD](https://gnomad.broadinstitute.org/) and 1000 Genomes report that the minor T allele is most prevalent among European populations, where it exhibits an allele frequency of approximately 0.35. In contrast, the minor allele frequency drops significantly to roughly 0.10 in East Asian populations, and it is observed at even lower frequencies in certain African cohorts. Because the frequency of the protective T allele varies across global lineages, baseline statistical risk estimates derived primarily from Caucasian cohorts cannot be assumed to carry identical predictive value in understudied ancestral populations. Researchers emphasize that multigenic risk profiling must account for these continental baseline differences to avoid biased conclusions in diverse clinical cohorts.

Interpreting Your Results and Actionable Boundaries

Finding rs11556924 in your genetic raw data provides an interesting glimpse into cell cycle genetics, but it cannot be used to diagnose coronary artery disease, predict a heart attack, or replace clinical evaluation. Because this polymorphism contributes a minor effect within a complex web of risk factors, it does not mandate specific medical interventions or prescriptions. Standard preventative cardiovascular measures remain identical regardless of whether you carry the higher-risk C allele or the protective T allele: maintain healthy blood pressure, monitor lipid panels, eat a balanced diet, engage in regular aerobic exercise, and avoid tobacco use. If you have concerns about your family history of heart disease, discuss comprehensive cardiovascular screening and validated clinical risk calculators with a physician.

Frequently asked questions

Sources & further reading